Sector Chart Resverlogix Corp. OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
20:47:54 27/05/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0731 USD | +1.53% |
|
-4.82% | -1.48% |
| 08-14 | Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-26 | Resverlogix Corp. - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 69.54B | |||||
| 64.97B | |||||
| 26.51B | |||||
| 25.89B | - | ||||
| 25.64B | - |
Select your edition
All financial news and data tailored to specific country editions
